Cargando…

Essentials of Atrial Fibrillation

This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1-2% of the population and i...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Yap, Yee Guan (Autor), Camm, A John (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Tarporley : Springer Healthcare Ltd. : Imprint: Springer Healthcare, 2014.
Edición:1st ed. 2014.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-907673-98-6
003 DE-He213
005 20220114190151.0
007 cr nn 008mamaa
008 140925s2014 xxk| s |||| 0|eng d
020 |a 9781907673986  |9 978-1-907673-98-6 
024 7 |a 10.1007/978-1-907673-98-6  |2 doi 
050 4 |a RC1-1245 
072 7 |a MJ  |2 bicssc 
072 7 |a MED045000  |2 bisacsh 
072 7 |a MJ  |2 thema 
082 0 4 |a 616  |2 23 
100 1 |a Yap, Yee Guan.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Essentials of Atrial Fibrillation  |h [electronic resource] /  |c by Yee Guan Yap, A John Camm. 
250 |a 1st ed. 2014. 
264 1 |a Tarporley :  |b Springer Healthcare Ltd. :  |b Imprint: Springer Healthcare,  |c 2014. 
300 |a VIII, 47 p. 11 illus., 4 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Epidemiology of atrial fibrillation -- Pathogenesis of atrial fibrillation -- Classification, diagnosis, and assessment of atrial fibrillation -- Rate and rhythm control strategies for atrial fibrillation -- Anticoagulant treatment strategies for atrial fibrillation. 
520 |a This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1-2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events. 
650 0 |a Internal medicine. 
650 0 |a Public health. 
650 0 |a Cardiology. 
650 0 |a Hematology. 
650 0 |a Primary care (Medicine). 
650 0 |a Therapeutics. 
650 1 4 |a Internal Medicine. 
650 2 4 |a Public Health. 
650 2 4 |a Cardiology. 
650 2 4 |a Hematology. 
650 2 4 |a Primary Care Medicine. 
650 2 4 |a Therapeutics. 
700 1 |a Camm, A John.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781858734385 
776 0 8 |i Printed edition:  |z 9781907673993 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-907673-98-6  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)